Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson’s and Alzheimer’s diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and micro granules. The company was founded in 2008 and is based in Taipei, Taiwan.
Metrics to compare | 4166 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4166PeersSector | |
---|---|---|---|---|
P/E Ratio | 70.4x | −60.1x | −0.6x | |
PEG Ratio | 0.21 | −1.01 | 0.00 | |
Price/Book | 4.7x | 2.6x | 2.6x | |
Price / LTM Sales | 7.9x | 6.3x | 3.1x | |
Upside (Analyst Target) | - | 0.0% | 48.7% | |
Fair Value Upside | Unlock | −11.7% | 7.7% | Unlock |